Rachana M Palnitkar, MD
Infectious Disease · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 8 carriers
- Office
- 1
Offices
1 location
Hospitals listed: 757662 · El Camino Health · Good Samaritan Hospital · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
29 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Palnitkar’s office at (408) 374-5340 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A111367 · Current
Licensed to practise in California · since 2010 · expires 2028-03-31 · University of Mumbai, Topiwala National Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$200,722
Medicare paid this office $200,722 for 540 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 327 | $100,536 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 477 | $72,208 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 157 | $14,335 | $66 |
| Short return visit (20+ min) | 54 | $7,074 | $80 |
| Return visit (30+ min) | 26 | $4,151 | $115 |
See all 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 327 | $100,536 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 477 | $72,208 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 157 | $14,335 | $66 |
| Short return visit (20+ min) | 54 | $7,074 | $80 |
| Return visit (30+ min) | 26 | $4,151 | $115 |
| New patient visit (45+ min) | 14 | $1,925 | $138 |
Who their Medicare patients are
540 Original Medicare patients in 2024. Average age 78 · Under 65 5% · 85 and older 26% · Women 49% · Also on Medicaid 31% · Health risk score 2.79. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 55% · Chronic kidney disease 53% · Heart failure 52% · Coronary heart disease 51% · Atrial fibrillation 45% · Depression 33% · Dementia 31% · COPD 30% · Cancer 23% · Stroke 20%.
The office billed $350,069, Medicare allowed $255,953 and paid $200,722; for 1,882 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 540 | 1,882 | 78 | 2.79 | $350,069 | $200,722 |
| 2023 | 554 | 1,863 | 77 | 2.48 | $350,375 | $216,499 |
| 2022 | 569 | 1,922 | 78 | 2.47 | $352,465 | $222,173 |
| 2021 | 546 | 1,833 | 78 | 2.59 | $325,595 | $215,926 |
| 2020 | 507 | 2,035 | 78 | 2.53 | $329,325 | $234,449 |
| 2019 | 437 | 1,851 | 78 | 2.71 | $291,073 | $204,314 |
| 2018 | 378 | 1,426 | 77 | 2.59 | $229,359 | $154,835 |
| 2017 | 360 | 1,645 | 77 | 2.71 | $253,288 | $171,256 |
| 2016 | 355 | 1,883 | 77 | 2.62 | $278,705 | $192,983 |
| 2015 | 301 | 1,698 | 77 | 2.47 | $244,042 | $173,584 |
| 2014 | 223 | 1,209 | 75 | 2.37 | $171,048 | $124,155 |
| 2013 | 222 | 1,151 | 76 | 2.50 | $159,267 | $111,849 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 357 | $114,204 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 476 | $80,537 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $11,974 | $71 |
| Short return visit (20+ min) | 44 | $5,507 | $82 |
| Return visit (30+ min) | 19 | $2,566 | $122 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 337 | $105,311 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 519 | $99,960 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $7,975 | $64 |
| Short return visit (20+ min) | 35 | $4,299 | $86 |
| Return visit (30+ min) | 15 | $2,214 | $123 |
| New patient visit (45+ min) | 12 | $1,907 | $159 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 361 | $102,674 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 478 | $92,437 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $10,176 | $67 |
| Short return visit (20+ min) | 34 | $4,777 | $88 |
| Return visit (30+ min) | 25 | $3,062 | $122 |
| New patient visit (45+ min) | 14 | $2,282 | $163 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 344 | $130,202 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 438 | $87,345 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 92 | $8,433 | $67 |
| Return visit (30+ min) | 26 | $3,313 | $104 |
| New patient visit (45+ min) | 12 | $1,905 | $159 |
| Short return visit (20+ min) | 20 | $1,633 | $74 |
2019: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 307 | $120,883 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 359 | $68,783 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $7,169 | $65 |
| Return visit (30+ min) | 23 | $2,880 | $103 |
| New patient visit (45+ min) | 12 | $1,837 | $153 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 260 | $80,566 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 305 | $58,598 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 114 | $9,259 | $63 |
| Return visit (30+ min) | 23 | $2,414 | $97 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 287 | $102,630 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 303 | $56,589 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $7,776 | $62 |
| Short return visit (20+ min) | 22 | $1,794 | $62 |
| Return visit (30+ min) | 11 | $1,070 | $97 |
2016: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 275 | $124,677 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 270 | $54,585 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $8,443 | $63 |
| Short return visit (20+ min) | 32 | $2,965 | $66 |
| New patient visit (45+ min) | 12 | $1,626 | $136 |
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 255 | $117,099 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 228 | $45,071 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $6,578 | $64 |
| Short return visit (20+ min) | 36 | $3,350 | $67 |
2014: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 193 | $88,801 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 157 | $29,319 | $180 |
| Short return visit (20+ min) | 36 | $3,406 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,345 | $64 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 177 | $70,944 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 137 | $27,327 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $7,989 | $62 |
| Short return visit (20+ min) | 30 | $3,213 | $66 |
| Short return visit | 11 | $672 | $42 |
Medicaid work
$5,453 in 2024
Medicaid paid $5,453 for 302 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSP IP/OBS HIGH 75 | 101 | $2,996 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 201 | $2,457 |
| 2024 | 302 | 2 | 23 | $5,453 |
| 2023 | 651 | 2 | 31 | $12,513 |
| 2022 | 608 | 2 | 29 | $10,793 |
| 2021 | 265 | 2 | 28 | $5,390 |
| 2020 | 209 | 2 | 20 | $4,934 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 461 | $7,825 |
| 1ST HOSP IP/OBS HIGH 75 | 190 | $4,688 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 404 | $6,578 |
| 1ST HOSP IP/OBS HIGH 75 | 204 | $4,215 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 171 | $3,214 |
| 1ST HOSP IP/OBS HIGH 75 | 94 | $2,176 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 163 | $3,659 |
| 1ST HOSP IP/OBS HIGH 75 | 46 | $1,275 |
Drugs they prescribed that Part D paid
$131,858
Pharmacies billed $131,858 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 423) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
373 generic and 50 brand-name prescriptions · $131,858 in drug cost · 322 antibiotic prescriptions to 74 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 19 | $91,243 | $4,802 |
| Vancomycin | 36 | $5,614 | $156 |
| Daptomycin | 12 | $4,138 | $345 |
| Meropenem | 32 | $3,866 | $121 |
| Ceftriaxone | 48 | $3,592 | $75 |
See all 13 drugs
| Biktarvy | 19 | $91,243 | $4,802 |
| Vancomycin | 36 | $5,614 | $156 |
| Daptomycin | 12 | $4,138 | $345 |
| Meropenem | 32 | $3,866 | $121 |
| Ceftriaxone | 48 | $3,592 | $75 |
| Ampicillin-Sulbactam | 31 | $2,014 | $65 |
| Amoxicillin-Clavulanate Potass | 41 | $1,078 | $26 |
| Atovaquone-Proguanil | 14 | $993 | $71 |
| Sulfamethoxazole-Trimethoprim | 17 | $327 | $19 |
| Levofloxacin | 15 | $258 | $17 |
| Valacyclovir | 18 | $184 | $10 |
| Cephalexin | 15 | $182 | $12 |
| Ciprofloxacin | 19 | $81 | $4 |
Year by year
| 2024 | 423 | 84 | 0% (0) | 12% | $131,858 |
| 2023 | 267 | 67 | 0% (0) | 13% | $120,953 |
| 2022 | 205 | 42 | 0% (0) | 12% | $88,441 |
| 2021 | 222 | 47 | 0% (0) | 14% | $115,450 |
| 2020 | 244 | 51 | 0% (0) | 18% | $150,398 |
| 2019 | 229 | 75 | 0% (0) | 21% | $96,054 |
| 2018 | 162 | 57 | 0% (0) | 29% | $68,051 |
| 2017 | 145 | 55 | 0% (0) | 39% | $71,915 |
| 2016 | 197 | 70 | 0% (0) | 22% | $82,644 |
| 2015 | 183 | 55 | 0% (0) | 32% | $54,895 |
| 2014 | 143 | 39 | 0% (0) | 23% | $54,583 |
| 2013 | 132 | 43 | 0% (0) | None | $30,694 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Daptomycin | 18 | $10,513 | $584 |
| Vancomycin | 29 | $6,457 | $223 |
| Efavirenz | 13 | $5,823 | $448 |
| Atovaquone-Proguanil | 13 | $1,124 | $86 |
| Itraconazole | 13 | $945 | $73 |
| Cephalexin | 23 | $886 | $39 |
| Levofloxacin | 15 | $566 | $38 |
| Ciprofloxacin | 17 | $431 | $25 |
| Amoxicillin-Clavulanate Potass | 14 | $336 | $24 |
2022: 9 drugs
| Genvoya | 13 | $49,628 | $3,818 |
| Efavirenz | 16 | $5,781 | $361 |
| Ceftriaxone | 24 | $3,771 | $157 |
| Vancomycin | 13 | $2,479 | $191 |
| Emtricitabine-Tenofovir Disop | 11 | $1,046 | $95 |
| Itraconazole | 13 | $753 | $58 |
| Cephalexin | 16 | $672 | $42 |
| Valacyclovir | 13 | $662 | $51 |
| Cefazolin | 16 | $372 | $23 |
2021: 9 drugs
| Genvoya | 11 | $39,766 | $3,615 |
| Efavirenz | 13 | $8,251 | $635 |
| Vancomycin | 25 | $3,455 | $138 |
| Cefazolin | 20 | $1,571 | $79 |
| Itraconazole | 13 | $926 | $71 |
| Valacyclovir | 12 | $909 | $76 |
| Ceftriaxone | 12 | $497 | $41 |
| Cephalexin | 11 | $383 | $35 |
| Amoxicillin | 14 | $331 | $24 |
2020: 10 drugs
| Efavirenz | 23 | $20,895 | $908 |
| Ertapenem | 13 | $18,369 | $1,413 |
| Vancomycin | 14 | $5,587 | $399 |
| Ceftriaxone | 26 | $3,011 | $116 |
| Rifampin | 28 | $1,681 | $60 |
| Itraconazole | 12 | $1,037 | $86 |
| Ethambutol | 20 | $929 | $46 |
| Valacyclovir | 12 | $831 | $69 |
| Sodium Chloride | 13 | $610 | $47 |
| Azithromycin | 11 | $404 | $37 |
2019: 6 drugs
| Ampicillin | 19 | $2,695 | $142 |
| Atovaquone-Proguanil | 31 | $2,036 | $66 |
| Itraconazole | 13 | $1,088 | $84 |
| Valacyclovir | 11 | $669 | $61 |
| Azithromycin | 16 | $219 | $14 |
| Ciprofloxacin | 25 | $105 | $4 |
2018: 6 drugs
| Ampicillin-Sulbactam | 19 | $2,480 | $131 |
| Atovaquone-Proguanil | 15 | $1,242 | $83 |
| Valacyclovir | 14 | $971 | $69 |
| Sodium Chloride | 13 | $284 | $22 |
| Ciprofloxacin | 17 | $63 | $4 |
| Azithromycin | 12 | $60 | $5 |
2017: 4 drugs
| Atovaquone-Proguanil | 21 | $1,879 | $89 |
| Valacyclovir | 11 | $653 | $59 |
| Sodium Chloride | 14 | $375 | $27 |
| Ciprofloxacin | 13 | $60 | $5 |
2016: 7 drugs
| Ampicillin | 19 | $7,830 | $412 |
| Vancomycin | 14 | $6,003 | $429 |
| Ceftriaxone | 21 | $1,133 | $54 |
| Azithromycin | 17 | $945 | $56 |
| Atovaquone-Proguanil | 16 | $870 | $54 |
| Valacyclovir | 14 | $577 | $41 |
| Ciprofloxacin | 22 | $99 | $4 |
2015: 6 drugs
| Ceftriaxone | 17 | $7,139 | $420 |
| Ethambutol | 14 | $1,917 | $137 |
| Azithromycin | 19 | $1,665 | $88 |
| Atovaquone-Proguanil | 14 | $1,086 | $78 |
| Rifampin | 11 | $656 | $60 |
| Ciprofloxacin | 13 | $55 | $4 |
2014: 5 drugs
| Ethambutol | 17 | $842 | $50 |
| Azithromycin | 19 | $824 | $43 |
| Valacyclovir | 14 | $484 | $35 |
| Amox Tr-Potassium Clavulanate | 12 | $347 | $29 |
| Sulfamethoxazole-Trimethoprim | 12 | $58 | $5 |
2013: 2 drugs
| Valacyclovir | 14 | $770 | $55 |
| Sulfamethoxazole-Trimethoprim | 20 | $215 | $11 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2019 | 2 | 2 | None | $148 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Melinta Therapeutics | Rezzayo | $125 | 1 payment
|
See the published payment
| Melinta Therapeutics | Meals · 2025-01-16 | Rezzayo | $125 |
See earlier years (2019)
2019: $148
| Insmed | None | $125 | 1 payment
|
| Edwards Lifesciences | Clearsight System | $23 | 1 payment
|
Checkups this office reported
7 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 71.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Checked for fall riskOlder patients screened for fall risk | 87%That's most of the people this applied to. | 83 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 248 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 2%That's few of the people this applied to. | 84 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 110 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 85 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 66% | 224 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 88%That's most of the people this applied to. | 162 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- COVID-19 Vaccine Achievement for Practice Staff
- Did a security review of patient data
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- ONC-ACB Surveillance Attestation
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Records advance care plans
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
- Exempt from support electronic referral loops by receiving and reconciling health information
- Exempt from support electronic referral loops by sending health information
Professional record
- NPI
- 1508050790
- Licence
- CA A111367California A111367: Current · expires 2028-03-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 14901 National Ave, Suite 202, Los Gatos, CA, 95032
- NPI first listed
- 2007-08-30
- NPI last updated
- 2024-02-22
- NPI record certified
- 2024-02-22
This is when the NPI record was last certified, not a medical board exam.